In March 2010, legislators signed into law the landmark health care reform bill. This reform was highly praised by the Personalized Medicine Coalition who stated that the bill represents the "first time the principles of personalized medicine were formally voted on and passed by both houses of Congress and signed into law by a president." Director of the Personalized Medicine Coalition, Amy Miller, stated that the have "been working over the past year in support of policy solutions that listen to the science and advance the interest of patients by incorporating personalized medicine into comparative effective research." This bill will lead to the creation of a Patient Centered Outcomes Research Institute, which will be in charge of informing the public of the risks and benefits of marketed drugs. It is also responsible for examining the effectiveness of these drugs in regard to various subpopulations differentiated by race, sex, age and genetic categories.(3)
Learn more about the new health care plan: http://www.healthreform.gov/
